Literature DB >> 8395404

Declining lymphocyte counts following cytomegalovirus (CMV) infection are associated with fatal CMV disease in bone marrow transplant patients.

B C Fries1, D Khaira, M S Pepe, B Torok-Storb.   

Abstract

A previous pilot study conducted on 12 bone marrow transplant recipients suggested that detection of cytomegalovirus (CMV) in lymphocytes was associated with a drop in lymphocyte counts and death due to CMV disease. To test the association between decreasing lymphocytes and CMV-related death, we undertook a retrospective study of 332 CMV-infected patients transplanted between 1987 and 1990. The patients were divided into three groups: I = 170 patients who survived their infection and were alive at the time of the study; II = 103 patients who died of causes other than CMV infection; and III = 59 patients who died of CMV disease. Lymphocyte counts were analyzed during a 24-day period, starting 10 days before the day of first positive CMV culture (day 0). Lymphocyte counts were significantly lower in Group III from day 0 through day +14 (p < .001 vs. group I; and p = .002 vs. group II). Multivariate statistical analysis was used to adjust for other differences between the groups that might influence lymphocyte numbers. Average lymphocyte counts in patients who died of CMV disease decreased by an average of 35% after day 0. The differences in lymphocyte counts remained independent of the effects of acute graft-vs.-host disease (GVHD), time since transplant, transplant type, and high-dose steroid treatment. In summary, these data suggest that in some patients a drop in lymphocyte counts is a consequence of CMV infection associated with fatal CMV disease. Whether this can be attributed to direct infection of lymphocytes, a defective immune response, or some other mechanism remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8395404

Source DB:  PubMed          Journal:  Exp Hematol        ISSN: 0301-472X            Impact factor:   3.084


  9 in total

1.  Cytomegalovirus inhibits the engraftment of donor bone marrow cells by downregulation of hemopoietin gene expression in recipient stroma.

Authors:  H P Steffens; J Podlech; S Kurz; P Angele; D Dreis; M J Reddehase
Journal:  J Virol       Date:  1998-06       Impact factor: 5.103

2.  Bone marrow failure by cytomegalovirus is associated with an in vivo deficiency in the expression of essential stromal hemopoietin genes.

Authors:  A Mayer; J Podlech; S Kurz; H P Steffens; S Maiberger; K Thalmeier; P Angele; L Dreher; M J Reddehase
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

3.  Tumor control in a model of bone marrow transplantation and acute liver-infiltrating B-cell lymphoma: an unpredicted novel function of cytomegalovirus.

Authors:  Katja C Erlach; Jürgen Podlech; Aysel Rojan; Matthias J Reddehase
Journal:  J Virol       Date:  2002-03       Impact factor: 5.103

4.  Absolute Lymphocyte Count: A Predictor of Recurrent Cytomegalovirus Disease in Solid Organ Transplant Recipients.

Authors:  Bradley J Gardiner; Natalie E Nierenberg; Jennifer K Chow; Robin Ruthazer; David M Kent; David R Snydman
Journal:  Clin Infect Dis       Date:  2018-10-15       Impact factor: 9.079

5.  Human Cytomegalovirus miRNAs Regulate TGF-β to Mediate Myelosuppression while Maintaining Viral Latency in CD34+ Hematopoietic Progenitor Cells.

Authors:  Meaghan H Hancock; Lindsey B Crawford; Andrew H Pham; Jennifer Mitchell; Hillary M Struthers; Andrew D Yurochko; Patrizia Caposio; Jay A Nelson
Journal:  Cell Host Microbe       Date:  2019-12-19       Impact factor: 21.023

6.  Effect of Ex Vivo-Expanded Recipient Regulatory T Cells on Hematopoietic Chimerism and Kidney Allograft Tolerance Across MHC Barriers in Cynomolgus Macaques.

Authors:  Raimon Duran-Struuck; Hugo P Sondermeijer; Leo Bühler; Paula Alonso-Guallart; Jonah Zitsman; Yojiro Kato; Anette Wu; Alicia N McMurchy; David Woodland; Adam Griesemer; Mercedes Martinez; Svetlan Boskovic; Tatsuo Kawai; A Benedict Cosimi; Yong-Guang Yang; Zheng Hu; Cheng-Shie Wuu; Andrea Slate; Markus Mapara; Sam Baker; Rafal Tokarz; Vivette D'Agati; Scott Hammer; Marcus Pereira; W Ian Lipkin; Thomas Wekerle; Megan Levings; Megan Sykes
Journal:  Transplantation       Date:  2017-02       Impact factor: 4.939

Review 7.  Human Cytomegalovirus Host Interactions: EGFR and Host Cell Signaling Is a Point of Convergence Between Viral Infection and Functional Changes in Infected Cells.

Authors:  Byeong-Jae Lee; Chan-Ki Min; Meaghan Hancock; Daniel N Streblow; Patrizia Caposio; Felicia D Goodrum; Andrew D Yurochko
Journal:  Front Microbiol       Date:  2021-05-07       Impact factor: 5.640

Review 8.  [Diagnosis of lymphocytopenia].

Authors:  Alice Berezné; Wafaa Bono; Loïc Guillevin; Luc Mouthon
Journal:  Presse Med       Date:  2006-05       Impact factor: 1.228

9.  [Lymphocytopenia: aetiology and diagnosis, when to think about idiopathic CD4(+) lymphocytopenia?].

Authors:  A Régent; N Kluger; A Bérezné; K Lassoued; L Mouthon
Journal:  Rev Med Interne       Date:  2012-05-30       Impact factor: 0.728

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.